SCHEMBL3330874

SCHEMBL3330874

Cc1ccc(N[C@H]2CC[C@H](C(=O)N3CCN(C4CCC4)CC3)CC2)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.51
CCR2 P41597 1/20 0.46
KCNH2 Q12809 1/20 0.46
HTT P42858 3/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
USP2 O75604 1/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
TSHR P16473 1/20 0.45
EPHX2 P34913 1/20 0.45
HRH3 Q9Y5N1 2/20 0.43
IRAK4 Q9NWZ3 2/20 0.43
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
THRB P10828 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3326338 1.00 GFER (0.51) GFERCCR2KCNH2HTTL3MBTL1
SCHEMBL3327126 1.00 GFER (0.51) GFERCCR2KCNH2HTTL3MBTL1
SCHEMBL3325311 0.98 GFER (0.54) GFERCCR2KCNH2HTTL3MBTL1
SCHEMBL3325863 0.98 GFER (0.54) GFERCCR2KCNH2HTTL3MBTL1
SCHEMBL3323850 0.95 GFER (0.50) GFERCCR2KCNH2HTTL3MBTL1
SCHEMBL3325780 0.85 LMNA (0.52) KCNH2HTTHRH3LMNA
SCHEMBL3326452 0.85 LMNA (0.52) KCNH2HTTHRH3LMNA
SCHEMBL3325775 0.85 LMNA (0.52) KCNH2HTTHRH3LMNA
SCHEMBL3324820 0.83 GFER (0.49) GFERCCR2KCNH2HTTL3MBTL1
SCHEMBL3326261 0.83 GFER (0.49) GFERCCR2KCNH2HTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100120769-A1 CYCLOHEXYL PIPERAZINYL METHANONE DERIVATIVES NETTEKOVEN MATTHIAS 2010-05-13 US disclosed
CN-101374825-A Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators HOFFMANN LA ROCHE (CH) 2009-02-25 CN disclosed
US-20070167436-A1 Cyclohexyl piperazinyl methanone derivatives HOFFMANN-LA ROCHE INC. 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120769-A1 CYCLOHEXYL PIPERAZINYL METHANONE DERIVATIVES HRH3, HRH4, HRH1 GFER 3334/4885CCR2 260/4885KCNH2 455/4885
US-20070167436-A1 Cyclohexyl piperazinyl methanone derivatives HRH3, HRH4, HRH1 GFER 3334/4885CCR2 260/4885KCNH2 455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.